Sustained intake of paracetamol (acetaminophen) during oral anticoagulant therapy with coumarins does not cause clinically important INR changes: A randomized double-blind clinical trial

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 4, 2003, Pages 714-717

  Gadisseur, A P A ^a,b   Van Der Meer, F J M ^a,b   Rosendaal, F R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Leiden Anticoagulation Clinic   (Netherlands)

Author keywords

Anticoagulation; Coumarins; INR; Paracetamol

Indexed keywords

ANTICOAGULANT AGENT; COUMARIN DERIVATIVE; PARACETAMOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG INTERACTION; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL;

ACETAMINOPHEN; ADULT; AGED; ANTICOAGULANTS; COUMARINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROTHROMBIN TIME;

EID: 0142197163     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00135.x     Document Type: Article

References (15)

1. Rosendaal FR. The Scylla and Charybdis of oral anticoagulant treatment. N Engl J Med 1996; 335: 587-9.
2. Hylek E, Skates S, Sheehan M, Singer D. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with non-rheumatic atrial fibrillation. N Engl J Med 1996; 335: 540-6.
3. Cannegieter SC, Rosendaal FR, Wintzen AR, Van der Meer FJM, Vandenbroucke JP, Briet E. Optimal anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1996; 333: 11-7.
4. Fihn S, Mcdonell M, Martin D, Henikoff J, Vermes D, Kent D, White RH. Risk factors for complications of chronic anticoagulation. Ann Intern Med 1993; 118: 511-20.
5. Fihn S, Callahan C, Martin D, Mcdonell M, Henikoff J, White R. The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med 1996; 124: 970-9.
6. Van der Meer FJM, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy: an analysis of risk factors. Arch Intern Med 1993; 153: 1557-62.
7. Van der Meer FJM, Rosendaal FR, Vandenbroucke JP, Briet E. Assessments of a bleeding risk index in two cohorts of patients treated with oral anticoagulants. Thromb Haemost 1996; 76: 12-6.
8. Van den Besselaar AMHP, Van der Meer FJM, Gerrits-Drabbe C. Therapeutic control of oral anticoagulant treatment in the Netherlands. Am J Clin Pathol 1988; 153: 1557-62.
9. Antlitz AM, Mead JA Jr, Tolentino MA. Potentiation of oral anticoagulant therapy by acetaminophen. Curr Ther Res Clin Exp 1968; 10: 501-7.
10. Antlitz AM, Await LF. A double blind study of acetaminophen used in conjunction with oral anticoagulant therapy. Curr Ther Res Clin Exp 1969; 11: 360-1.
11. Udall J. Drug interference with warfarin therapy. Clin Med 1970; 26: 22-5.
12. Boeijinga JJ, Boerstra EE, Ris P, Breimer DD. Jeletich-Bastiaanse A. Interaction between paracetamol and coumarin anticoagulants. Lancet 1982; 1: 506.
13. Hylek E, Heiman H, Skates S, Sheehan M, Singer D. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 1998; 279: 657-62.
14. Amato MG, Bussey H, Farnett L, Lyons R. Acetaminophen and risk factors for excess anticoagulation with warfarin. JAMA 1998; 280: 695-6.
15. Riser J, Gilroy C, Hudson P, McCay L, Willis TA. Acetaminophen andrisk factors for excess anticoagulation with warfarin. JAMA 1998; 280: 696.